Education
About Us
Working with TipRanks
Follow Us
Lemaitre Vascular (LMAT)
NASDAQ:LMAT
LMAT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$62.39 - $109.58
Previous CloseN/A
Volume40.91K
Average Volume (3M)273.31K
Market Cap
$1.89B
Enterprise Value$2.00B
Total Cash (Recent Filing)$23.66M
Total Debt (Recent Filing)$149.00K
Price to Earnings (P/E)43.3
Beta0.80
Next Earnings
May 01, 2025EPS Estimate
0.5Last Dividend Ex-Date
Mar 13, 2025Dividend Yield0.82%
Share Statistics
EPS (TTM)1.93
Shares Outstanding22,558,632
10 Day Avg. Volume248,333
30 Day Avg. Volume273,305
Financial Highlights & Ratios
PEG Ratio0.97
Price to Book (P/B)N/A
Price to Sales (P/S)8.57
Price to Cash Flow (P/CF)31.00
P/FCF Ratio30.70
Enterprise Value/Market Cap1.06
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit13.23
Enterprise Value/Ebitda29.90
Forecast
1Y Price Target
$105.83Price Target Upside26.32% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
---
Lemaitre Vascular News
PremiumCompany Announcements
LeMaitre Vascular’s Earnings Call Highlights Robust Growth
PremiumCompany Announcements
LeMaitre Vascular Reports Strong Q4 2024 Results
---
Bulls Say, Bears Say
Bulls Say
Pricing StrategyLeMaitre implemented an 8% list price increase, surpassing previous years' hikes, indicating strong pricing power.
Sales ExpansionPlans to expand the sales force significantly suggest potential for increased market penetration and revenue growth.
Bears Say
Investment RatingLMAT shares were downgraded to a MARKET PERFORM rating from OUTPERFORM due to valuation concerns.
Revenue PerformanceRevenue of $55.7 million fell short of expectations, casting doubt on the company's immediate financial performance.
---
Ownership Overview
10.74% Insiders
27.09% Mutual Funds
0.19% Other Institutional Investors
40.37% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LMAT FAQ
What was Lemaitre Vascular’s price range in the past 12 months?
Lemaitre Vascular lowest stock price was $62.39 and its highest was $109.58 in the past 12 months.
What is Lemaitre Vascular’s market cap?
Lemaitre Vascular’s market cap is $1.89B.
When is Lemaitre Vascular’s upcoming earnings report date?
Lemaitre Vascular’s upcoming earnings report date is May 01, 2025 which is in 16 days.
How were Lemaitre Vascular’s earnings last quarter?
Lemaitre Vascular released its earnings results on Feb 27, 2025. The company reported $0.49 earnings per share for the quarter, missing the consensus estimate of $0.493 by -$0.003.
Is Lemaitre Vascular overvalued?
According to Wall Street analysts Lemaitre Vascular’s price is currently Undervalued.
Does Lemaitre Vascular pay dividends?
Lemaitre Vascular pays a Quarterly dividend of $0.2 which represents an annual dividend yield of 0.82%. See more information on Lemaitre Vascular dividends here
What is Lemaitre Vascular’s EPS estimate?
Lemaitre Vascular’s EPS estimate is 0.5.
How many shares outstanding does Lemaitre Vascular have?
Lemaitre Vascular has 22,558,632 shares outstanding.
What happened to Lemaitre Vascular’s price movement after its last earnings report?
Lemaitre Vascular reported an EPS of $0.49 in its last earnings report, missing expectations of $0.493. Following the earnings report the stock price went down -8.067%.
Which hedge fund is a major shareholder of Lemaitre Vascular?
Currently, no hedge funds are holding shares in LMAT
---
Lemaitre Vascular Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$105.83 (26.32% Upside)
$105.83 (26.32% Upside)
Blogger Sentiment
Bullish
LMAT Sentiment 83%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 1.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $814.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 3.8%
Last 30 Days ▼ 3.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
30.63%
12-Months-Change
Fundamentals
Return on Equity
13.87%
Trailing 12-Months
Asset Growth
59.13%
Trailing 12-Months
Company Description
Lemaitre Vascular
Lemaitre Vascular (LMAT) is a medical device company focused on developing, manufacturing, and marketing devices for the treatment of peripheral vascular disease. The company operates in the healthcare sector, providing a range of products that include vascular grafts, patches, and stents, among others, which are used by vascular surgeons to treat conditions affecting veins and arteries outside of the heart.
---
LMAT Company Deck
---
LMAT Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
LeMaitre Vascular reported strong financial performance with significant sales growth across key product lines and geographies. The expansion in China and improvement in gross margins highlight strategic progress. While there are pending regulatory approvals and potential tariff impacts, the company's positive guidance for 2025 and robust financial health indicate a strong outlook.Read More>---
LMAT Stock 12 Month Forecast
Average Price Target
$105.83
▲(26.32% Upside)
Technical Analysis
Best Analysts Covering LMAT
1 Year
1 Year Success Rate
8/10 ratings generated profit
1 Year Average Return
+55.33%
reiterated a buy rating 2 months ago
Copying Jason Wittes's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +55.33% per trade.
---